On ECHEMI
Home > Drugs > Hunan Dongting Pharmaceutical Co., Ltd.
Hunan Dongting Pharmaceutical Co., Ltd.
  • Founded in:

    1997-03-26
  • Country:

    China China
  • Address:

    No. 16 Dongyan Road, Chenjiagang Community, Deshan Subdistrict Office, Changde Economic and Technological Development Zone, Hunan Province (No. 16 Dongyan Road, Deshan District, Changde City)
  • Tax NO.:

    914307001838043692
  • Registered Funds:

    309.624852 million yuan
  • Website:

  • Email:

Related Drugs
Clozapine orally disintegrating tablets
Name Description Content CAS NO. Registered Holders
Clozapine

Extracting pharmacological effects from the above information

More

Extracting pharmacological effects from the above information

5786-21-0 30
Alprazolam tablets
The main ingredient of this product is alprazolam, and its chemical name is: 1-methyl-6-phenyl-8-chloro-4H-〔1,2,4〕triazolo[4,3-α][1,4]benzodiazepine.
Name Description Content CAS NO. Registered Holders
Alprazolam

0
Maprotiline Hydrochloride Tablets
The main ingredient of this product is maprotiline hydrochloride, and its chemical name is: N-methyl-9,10-ethanoanthracene-9(10H)-propylamine hydrochloride.
Name Description Content CAS NO. Registered Holders
Maprotiline hydrochloride

This product is a tetracyclic antidepressant. Its main function is to selectively inhibit the reuptake of norepinephrine in the peripheral and central nervous systems, while having no effect on the reuptake of 5-hydroxytryptamine. Due to the reduction of norepinephrine reuptake, the concentration of norepinephrine in the synaptic cleft increases, which downregulates the α2 receptors in the presynaptic membrane and strengthens the action of the α1 receptors in the postsynaptic membrane, producing an antidepressant effect. This product also has an anti-anxiety effect, and its sedative, anticholinergic and blood pressure-lowering effects are relatively mild.

More

This product is a tetracyclic antidepressant. Its main function is to selectively inhibit the reuptake of norepinephrine in the peripheral and central nervous systems, while having no effect on the reuptake of 5-hydroxytryptamine. Due to the reduction of norepinephrine reuptake, the concentration of norepinephrine in the synaptic cleft increases, which downregulates the α2 receptors in the presynaptic membrane and strengthens the action of the α1 receptors in the postsynaptic membrane, producing an antidepressant effect. This product also has an anti-anxiety effect, and its sedative, anticholinergic and blood pressure-lowering effects are relatively mild.

10347-81-6 5
Glycopyrrolate Tablets
The main ingredients of this product are: glycopyrrolate. Molecular formula: C19H28BrNO3 Molecular weight: 398.34
Name Description Content CAS NO. Registered Holders
Glycopyrrolate

Quaternary ammonium anticholinergics can selectively act on the digestive tract, inhibit gastric juice secretion and regulate gastrointestinal motility. They can quickly relieve spasms, suppress acid, and relieve pain after taking them. They also have a stronger anti-salivation effect than atropine, but have no central anticholinergic activity.

More

Quaternary ammonium anticholinergics can selectively act on the digestive tract, inhibit gastric juice secretion and regulate gastrointestinal motility. They can quickly relieve spasms, suppress acid, and relieve pain after taking them. They also have a stronger anti-salivation effect than atropine, but have no central anticholinergic activity.

596-51-0 32
Sulpiride Injection
The main ingredient of this product is Sulpiride, and its chemical name is: N-[methyl-(1-ethyl-2-pyrrolidinyl)]-2-methoxy-5-(aminosulfonyl)-benzamide.
Name Description Content CAS NO. Registered Holders
Sulpiride

This product belongs to the benzamide antipsychotic drug. Its characteristic action is to selectively block the dopamine (DA2) receptors of the mesolimbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric juice secretion inhibitory effects.

More

This product belongs to the benzamide antipsychotic drug. Its characteristic action is to selectively block the dopamine (DA2) receptors of the mesolimbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric juice secretion inhibitory effects.

15676-16-1 12
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.